BridgeMD
New treatment option for Eye Cancer
Official title Suprachoroidal Administration in Subjects With Metastases to the Choroid
ClinicalTrials.gov ID: NCT06643884
What this study is testing
What is AU-011?
AU-011 is an investigational medicine, being studied as a potential treatment for eye cancer.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The primary objective is to assess the safety and tolerability of bel-sar treatment in subjects with metastases to the choroid from any primary solid tumor.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Have a clinical diagnosis of Metastases to the Choroid, from a histopathologically or cytologically confirmed tumor.
- Have at least one Metastases to the Choroid in the study eye
You likely can't join if
- Active ocular infection or disease.
- Must not have evidence of a primary tumor or metastatic lesion in the brain requiring treatment with radiation therapy per the primary treating...
- Must not be planning or expecting to switch/add systemic antineoplastic therapies during treatment
The study team makes the final eligibility decision.
Where it's taking place
- Palo Alto, California, United States
- Miami, Florida, United States
- Boston, Massachusetts, United States
- Ann Arbor, Michigan, United States
- Rochester, Minnesota, United States
- Cleveland, Ohio, United States
- Philadelphia, Pennsylvania, United States
- Nashville, Tennessee, United States
- Bellaire, Texas, United States
- Seattle, Washington, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Palo Alto, California, United States; Miami, Florida, United States; Boston, Massachusetts, United States; Ann Arbor, Michigan, United States; Rochester, Minnesota, United States; Cleveland, Ohio, United States and 4 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.